Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
Don’t Miss a Move in the ETF Market
Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.
ETFs with exposure to Guardant Health, Inc. (GH)
9.12% | +15.68% | +11.69% | +€1.7M | +€3.4M | €25M | 0.5% | Not rated | |
6.21% | +11.56% | +3.95% | -€2.7M | -€4.2M | €10M | 0.35% | ||
5.63% | +7.13% | -1.21% | €0 | €0 | €2.5M | 0.65% | ||
Global X Genomics & Biotechnology UCITS ETF - USD This ETF provides exposure to Developed markets Equities | 5.60% | +18.45% | +26.23% | +€6.3M | +€11M | €35M | 0.5% | |
5.59% | +18.59% | +26.50% | +€17M | +€16M | €75M | 0.5% | ||
Goldman Sachs Future Health Care Equity ETF - USD This ETF provides exposure to Other Global Equities | 5.35% | +9.55% | +1.75% | -€2.3M | -€2.1M | €17M | 0.75% | Not rated |
F/m Emerald Life Sciences Innovation ETF - USD This ETF provides exposure to Other Mid and Small-Cap Equities | 5.20% | +17.63% | +24.06% | +€1M | +€5.3M | €108M | 0.79% | Not rated |
3.89% | +5.08% | +33.18% | +€1.1M | +€6.7M | €30M | 0.89% | Not rated | |
Xtrackers World Small Cap Green Tech Innovators UCITS ETF 1C - USD This ETF provides exposure to Other Small Cap Equities | 3.75% | +2.14% | +14.38% | +€1.1M | +€35M | €73M | 0.45% | Not rated |
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C - USD This ETF provides exposure to Other Equities | 3.63% | +13.10% | +9.81% | €0 | +€2.1M | €8.9M | 0.25% | |
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
